Global Grand Rounds in ID (2020-4-22) - Part 2

Posted: 
2020-04-23
GGRID Case Conference
Description 

Dr. Robsinson speaks on practical considerations for COVID-19 Management.

  • NO drug has shown clinical efficacy for treatment of COVID-19 in a controlled trial
  • Existing drugs are under consideration as antivirals
  • Existing immunomodulators are under consideration to reduce lung injury
  • Experimental drugs are under study
Speaker: 
Dr. Matt Robinson
Disclosures: 
No Disclosures
Length of Presentation: 
27 minutes 43 seconds